Cross-clamp time showed a trend towards longer duration in males (56.0 ± 17.6 min) vs. females (51.3 ± 15.1 min), though this difference did not reach statistical significance ( p = 0.069).
← all phrases
“showed a trend”
In the literature
The FAD/chol cluster with poor prognosis showed a trend toward decreased prevalence of VHL mutations and higher c-MET copy numbers.
After specimen installation, the surface cavitation intensity showed a trend of initial increase followed by a decrease with increasing cavitation erosion distance.
For secondary collapse rates, Western studies (three studies, 295 patients) demonstrated a significantly higher risk with autografts compared to bone substitutes (RR = 1.45, 95%CI: 1.07, 1.97; P value = 0.02), while the single Asian study (74 patients) showed a trend in the opposite direction, however this was not statistically significant (RR = 0.56, 95%CI: 0.21, 1.50; P value = 0.25).
Presence of dyslipidemia (β −1.33, p-value = 0.122) and diabetes mellitus (β −1.82, p-value = 0.323) showed a trend of negative association with max.
In addition, when the RM particles were between 0.850 and 1.700 mm, the pellet strength showed a trend of first increasing and then decreasing with an increase in the proportion of large particles.
Analysis of the complete blood count showed a trend toward reduced circulating monocyte and neutrophil counts with BHB treatment; but these differences did not reach statistical significance.
However, when the cultures were treated with OI or DMF, a known Nrf2 activator, we observed significantly increased expression of EpoR , Gata1 , and Cpox with OI, whereas DMF significantly increased EpoR and showed a trend toward increased Gata1 and Cpox mRNA expression ( Figure 7C ).
While α-SMA expression showed a trend toward an increase under HG conditions, PPD treatment partially reversed this response, though statistical significance was not achieved ( p > 0.05) ( Figure 10C,F ).
Instead, we acknowledge that while cabergoline showed a trend toward faster prolactin normalization, our data did not show statistically significant differences in overall outcomes between cabergoline and bromocriptine.
A total of nine of these species showed a trend towards the NC group after BA intervention.
This is consistent with findings from the FinnDiane study and other cohorts in Latin America and Asia, which identify disease duration as a key determinant of vascular calcification and PAD [ 33 , 50 , 6 ] Interestingly, age was not significantly associated with AC in our cohort and even showed a trend toward higher prevalence in younger patients, suggesting that in certain individuals—possibly with specific metabolic or genetic profiles—calcification may develop early in the disease course.
Briefly, patients across all subgroups, except those with lung metastases, showed a trend towards superior PFS and OS with the anti-CTLA-4-based combination.
Although not statistically significant, the hard milled specimens also showed a trend toward reduced discrepancies post‐firing.
Nevertheless, Group A showed a trend toward improved DFS and OS compared to Group B, though the difference did not reach statistical significance (data not shown).
In addition, ATXL233-treated mice showed a trend of reduced liver fibrosis as determined by Sirius red staining, although not statistically significant ( Figures S7 A and S7B).
Although the other three measures did not reach statistical significance, the data showed a trend toward decreased β-catenin and Bcl-2 levels, and increased caspase levels.
Younger age showed a trend towards increased risk but did not reach statistical significance (p = 0.052).
Neutrophil count showed a trend toward association but did not reach statistical significance (OR: 1.62, 95% CI: 0.99–3.31; p =0.100).
The advanced stage (Stage IV: HR = 9.37; unknown stage: HR 10.30) showed a trend toward poorer outcomes, although not statistically significant.
In a North American cohort, combining HMP with short-term NMP (median 171 minutes) showed a trend toward reduced DGF compared with HMP alone. 23 In the Eurotransplant region, Rijkse et al. 22 reported a significant reduction in DGF after 2 hours of NMP compared with historical HMP-only controls; whereas in Australia, a paired study of 18 kidneys showed that 1 to 3 hours of NMP reduced DGF rates
Interestingly, 5‐days post‐MI, in sections from the upper region of the infarct (“A” sections), the abundance of CD206 immunoreactivity in the infarct border region of MI‐MK2 +/+ hearts showed a trend towards being greater than in MI‐MK2 −/− hearts, but the difference did not reach significance.
Comparison of Muscle Volume Change Proportions Between Graft Types Although the BPTB group showed a trend toward greater reduction in total thigh volume relative to the contralateral limb compared with the allograft group, this difference was not statistically significant ( P = .315).
Higher steroid doses showed a trend toward increased risk, but without statistical significance (p = 0.985).
Although sleep efficiency showed a trend toward association with depression, it did not reach statistical significance in our cohort.